EPS3.3 Plasma levels of the bioactive sphingolipid S1P are reduced in cystic fibrosis patients after lung transplantation depending on CFTR mutation. - Halilbasic, E.; Fuerst, E.; Heiden, D.; Japtok, L.; Diesner, S.C.; Hillebrand, P.; Vogelsang, H.; Trauner, M.; Kulu, A.; Jaksch, P.; Klepetko, W.; Kleuser, B.; et al. (Journal of Cystic Fibrosis, 2017)